Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.

Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft ...

Regarding blood loss and fusion rates, there was no significant difference between the two fusion procedures.

Theradaptive earned the FDA's investigational device exemption approval to broaden its clinical research for the OsteoAdapt SP implant, the company said Dec. 10 ...

The Company’s current portfolio of aprevo ® interbody fusion devices for the treatment of lumbar spine disease is commercially available in the U.S. “This 510(k) clearance is a major step forward in ...